Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hologic Inc (HOLX)

Hologic Inc (HOLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Wall Street Bullish or Bearish on Hologic Stock?

With a market cap of $16.7 billion, Hologic, Inc. (HOLX) is a global medical technology company focused on improving women’s health through the early detection and treatment of disease. It develops and supplies diagnostic assays, medical imaging systems, and surgical solutions across its Diagnostics, Breast Health, GYN Surgical, and Skeletal Health segments.

Shares of the Marlborough, Massachusetts-based company have slightly outperformed the broader market over the past 52 weeks. HOLX stock has increased 16.2% over this time frame, while the broader S&P 500 Index ($SPX) has gained 15.6%. However, the stock has risen marginally on a YTD basis, slightly lagging...

Fundamentals

See More
  • Market Capitalization, $K 16,763,466
  • Shares Outstanding, K 223,245
  • Annual Sales, $ 4,101 M
  • Annual Income, $ 565,700 K
  • EBIT $ 776 M
  • EBITDA $ 1,076 M
  • 60-Month Beta 0.72
  • Price/Sales 4.09
  • Price/Cash Flow 13.14
  • Price/Book 3.19

Options Overview Details

View History
  • Implied Volatility 7.13% (-2.46%)
  • Historical Volatility 2.38%
  • IV Percentile 4%
  • IV Rank 2.73%
  • IV High 70.57% on 09/17/25
  • IV Low 5.35% on 01/29/26
  • Expected Move (DTE 8) 0.40 (0.53%)
  • Put/Call Vol Ratio 2.05
  • Today's Volume 180
  • Volume Avg (30-Day) 625
  • Put/Call OI Ratio 4.54
  • Today's Open Interest 24,264
  • Open Int (30-Day) 19,655
  • Expected Range 74.69 to 75.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.08
  • Number of Estimates 7
  • High Estimate 1.14
  • Low Estimate 1.03
  • Prior Year 1.03
  • Growth Rate Est. (year over year) +4.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.50 +0.79%
on 02/04/26
75.36 -0.36%
on 01/27/26
+0.22 (+0.29%)
since 01/09/26
3-Month
74.09 +1.35%
on 11/14/25
75.36 -0.36%
on 01/27/26
+0.49 (+0.66%)
since 11/11/25
52-Week
51.90 +44.68%
on 05/06/25
75.36 -0.36%
on 01/27/26
+10.62 (+16.47%)
since 02/11/25

Most Recent Stories

More News
Is Wall Street Bullish or Bearish on Hologic Stock?

Though Hologic has outperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

HOLX : 75.09 (-0.08%)
XLV : 156.25 (+0.59%)
$SPX : 6,941.47 (unch)
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Expanded FDA approval across multiple cervical cancer screening modalities supports clinical flexibility and provider choice

HOLX : 75.09 (-0.08%)
Hologic: Fiscal Q1 Earnings Snapshot

Hologic: Fiscal Q1 Earnings Snapshot

HOLX : 75.09 (-0.08%)
Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates

Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates

HOLX : 75.09 (-0.08%)
Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases (9.2%), Non-GAAP Diluted EPS of $1.04 Up 1.0% –

HOLX : 75.09 (-0.08%)
Hologic (HOLX) Q4 Earnings: What To Expect

Hologic (HOLX) Q4 Earnings: What To Expect

HOLX : 75.09 (-0.08%)
1 Healthcare Stock Worth Investigating and 2 That Underwhelm

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

HOLX : 75.09 (-0.08%)
BRKR : 42.43 (+2.04%)
ELV : 330.25 (+1.42%)
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2026 on Thursday, January 29, after the market closes. As previously...

HOLX : 75.09 (-0.08%)
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

The Ultimate Defense campaign harnesses the power of sports to encourage lifesaving screening conversations

HOLX : 75.09 (-0.08%)
Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm as there may be limited time to enforce your rights.

HOLX : 75.09 (-0.08%)
VTYX : 13.94 (-0.14%)
TEX : 69.08 (+16.57%)
QRVO : 85.82 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

See More

Key Turning Points

3rd Resistance Point 75.41
2nd Resistance Point 75.34
1st Resistance Point 75.21
Last Price 75.09
1st Support Level 75.01
2nd Support Level 74.94
3rd Support Level 74.81

See More

52-Week High 75.36
Last Price 75.09
Fibonacci 61.8% 66.40
Fibonacci 50% 63.63
Fibonacci 38.2% 60.86
52-Week Low 51.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar